- •Contents
- •Introduction
- •Contributors
- •ROLE OF BIOPSY
- •DIRECTED TREATMENTS OF DISTINCT ORBITAL INFLAMMATIONS
- •ABSTRACT
- •ACKNOWLEDGEMENTS
- •5 Future and Emerging Treatments for Microbial Infections
- •MICROBIOLOGIC DIAGNOSIS
- •EMERGING ANTIBIOTIC RESISTANCE
- •HISTORICAL PERSPECTIVE
- •CURRENT APPROACH
- •FUTURE DIRECTIONS
- •7 Non-Hodgkin’s Lymphoma
- •INCIDENCE AND EPIDEMIOLOGY
- •ETIOLOGY AND RISK FACTORS
- •DIAGNOSIS, CLASSIFICATION, AND STAGING
- •TREATMENT
- •ABSTRACT
- •INTRODUCTION
- •STEPS TOWARD TUMOR SPECIFIC THERAPY
- •CANCER SPECIFIC MOLECULAR TARGETS
- •DNA ARRAY ANALYSIS
- •WHICH MOLECULAR TARGETS?
- •CONCLUSIONS
- •10 Malignant Lacrimal Gland Tumors
- •THERAPEUTIC RECOMMENDATIONS
- •SPHENOID WING MENINGIOMAS
- •Location
- •PRESENTING SIGNS AND SYMPTOMS
- •RADIOGRAPHIC IMAGING
- •ULTRASOUND
- •HISTOPATHOLOGY
- •TREATMENT AND PROGNOSIS
- •13 Stereotactic Radiotherapy for Optic Nerve and Meningeal Lesions
- •BACKGROUND
- •DEFINITIONS
- •Precise Immobilization
- •Precise Tumor Localization
- •Conformal Treatment Planning and Delivery
- •FUTURE DEVELOPMENTS
- •SUMMARY
- •ABSTRACT
- •INTRODUCTION
- •ABSTRACT
- •INTRODUCTION
- •Enzyme-Linked Immunosorbent Assay (ELISA)
- •Prospective Study of Graves’ Disease Patients
- •DISCUSSION
- •ACKNOWLEDGEMENTS
- •ORBITAL FIBROBLASTS DISPLAY CELL-SURFACE CD40 AND RESPOND TO CD154
- •CONCLUSIONS
- •ACKNOWLEDGEMENTS
- •INTRODUCTION
- •Retina, RPE, and Choroid
- •Optic Nerve
- •ACKNOWLEDGMENT
- •INTRODUCTION
- •METHODS
- •Historical Features
- •Tempo of Disease Onset
- •Clinical Features
- •DISCUSSION
- •19 Prognostic Factors
- •PREVENTION OF GRAVES’ OPHTHALMOPATHY BY EARLIER DIAGNOSIS AND TREATMENT OF GRAVES’ HYPERTHYROIDISM?
- •CLINICAL ACTIVITY SCORE
- •ORBITAL ECHOGRAPHY
- •ORBITAL OCTREOSCAN
- •ORBITAL MAGNETIC RESONANCE IMAGING
- •URINARY GLYCOSAMINOGLYCANS
- •SERUM CYTOKINES
- •CONCLUSION
- •BACKGROUND
- •VISA CLASSIFICATION
- •Strabismus
- •Appearance=Exposure
- •DISCUSSION
- •INTRODUCTION
- •NONSEVERE GRAVES’ OPHTHALMOPATHY
- •SEVERE GRAVES’ OPHTHALMOPATHY
- •Glucocorticoids
- •Orbital Radiotherapy
- •Immunosuppressive Drugs
- •Plasmapheresis
- •Somatostatin Analogues
- •Intravenous Immunoglobulins
- •Antioxidants
- •Cytokine Antagonists
- •Colchicine
- •INTRODUCTION
- •STABLE ORBITOPATHY
- •Preferred Decompression Techniques
- •EYE MUSCLE SURGERY
- •LID PROCEDURES
- •PATHOPHYSIOLOGY OF THE DISEASE
- •MEDICAL THERAPY
- •IMPROVEMENTS IN ORBITAL DECOMPRESSION
- •IMPROVEMENTS IN EYELID SURGERY
- •STRABISMUS SURGERY
- •Michael Kazim
- •John Kennerdell
- •Daphne Khoo
- •Claudio Marcocci
- •Jack Rootman
- •Wilmar Wiersinga
- •Answer
- •Question 1 (continued)
- •Answer
- •Question 2 (from M. Potts)
- •Answer
- •Question 2 (continued)
- •Question 3
- •Answer
- •Question 3 (continued)
- •Answer
- •Question 3 (continued)
- •Answer
- •Question 3 (continued)
- •Answer
- •Question 4 (from M. Mourits)
- •Answer
- •Question 5 (from F. Buffam)
- •Answer
- •Question 6 (from F. Buffam)
- •Answer
- •Question 7 (from P. Dolman)
- •Answer
- •INTRODUCTION
- •CLINICAL MANIFESTATIONS OF DVVMs
- •INVESTIGATION OF DVVMs
- •FUTURE CONSIDERATIONS
- •CONCLUSION
- •INTRODUCTION
- •CAROTID-CAVERNOUS SINUS FISTULAS
- •ARTERIOVENOUS MALFORMATIONS
- •DISTENSIBLE VENOUS ANOMALIES
- •PREOPERATIVE EMBOLIZATION OF TUMORS
- •ANEURYSMS
- •FUTURE DIRECTIONS
- •ABSTRACT
- •INTRODUCTION
- •TECHNOLOGICAL ADVANCEMENTS
- •Advances in Medical Imaging
- •Virtual Reality Surgical Simulation
- •Surgical Robotics
- •HUMAN BODY MODELS
- •FUTURE COMPUTER-AIDED ORBITAL SURGERY
- •SUMMARY
- •ACKNOWLEDGMENTS
- •30 The Future of Orbital Surgery
- •Index
Surgical Paradigms in Managing Thyroid Orbitopathy |
279 |
that there are two types of orbitopathy, one with more significant muscle involvement and the other dominated by expansion of the orbital fat (said to be more common amongst Asians). Generally, patients with significant expansion of orbital fat respond very well to decompressive techniques and offer a greater opportunity for fat resection. Evaluation of the orbital apex allows for determination of the roles of lateral, medial, and floor structures in potential decompression; evaluation of the sinus configuration and presence=absence of sinus disease may help in determining site and timing of decompression or need for adjunctive surgery. Some patients may have a particularly shallow orbit on imaging, implying the need to advance orbital bones or utilize an onlay technique. The bony structure, particularly the size of the marrow space and greater wing of sphenoid, may help in determining the potential for decompressive effect.
I have already mentioned that surgery on active disease may be associated with more complications and continued progression of disease, thus requiring vigilant postsurgical follow-up, continued medical care, and potentially repeat imaging. It is also worthy to note that inactive disease may reactivate following decompression and although this is a relatively rare event, we have seen it in a not insignificant number of patients (12). It should also be remembered that psychosocial factors may play an important role in determining the timing and nature of surgery for patients with Graves’ orbitopathy.
Preferred Decompression Techniques
There are multiple and variable technical options for decompression, which are listed in Table 1 (13). With regard to our own preferences, we tend toward minimal incision approaches using the medial caruncular incision with or without a lateral canthal incision. If, however, we are considering fat resection, we may utilize a swinging eyelid approach, which accesses the lower lid fat as well as the inferolateral orbit. This also can be augmented by a medial fat resection through the lid crease superomedially as well as a medial caruncular approach for
280 |
Rootman |
Table 1 Technical Options in Decompression
A.Floor and medial wall
1.Anterior Caruncular Medial skin
Medial upper eyelid
2.Sinus approach Ogura
Transnasal endoscopic
B.Lateral wall floor roof augmentation or bony advancement
1.Canthotomy
2.Swinging eyelid approach
3.Lateral upper eyelid approach
4.Burke–Kronlein þ medial approach
5.Burke–Kronlein þ Ogura or transnasal endoscopic
6.Coronal approach
C.Soft tissue
1.Orbital fat excision
2.Blepharoplasty
External
Internal
Modified with permission from Ref. 2 (p. 199).
decompression (14). Earlier, I noted that there are instances where we might combine mu¨ llerectomy or upper lid lengthening at the beginning of a decompressive surgery. This would be under local anesthetic and would be followed by the decompression under general anesthetic. The addition of blepharoplasty is also an option. We also favor a more minimal approach laterally by simply exposing the lateral wall through a canthal incision that does not involve incising the lateral canthal tendon.
EYE MUSCLE SURGERY
In our opinion, the sine qua non of eye muscle surgery is the use of adjustable sutures to achieve the best outcomes (15). In principle, we prefer to use recessions vs. resections, since this is a cicatricial disease. The intraoperative rule of thumb is
Surgical Paradigms in Managing Thyroid Orbitopathy |
281 |
that one can achieve 2.5 diopters per mm of recession; however, the fewer the muscles involved, the more one can achieve per mm.
It is important to be aware of the potential for consecutive deviations in surgical management of strabismus related to Graves’ orbitopathy. These tend to occur when the surgeon fails to recognize ipsilateral agonist involvement, leading to an overcorrection. This can be avoided by careful forced duction test as a primary aspect of corrective strabismus surgery.
LID PROCEDURES
The three major procedures for managing lid malpositions are mu¨ llerectomy, lower lid elevation, and blepharoplasty. As mentioned earlier, these are infrequently combined with decompressive surgery but usually are done subsequent to either decompression or strabismus surgery.
Mu¨ llerectomy can be achieved either through an internal conjunctival or an anterior approach (16–18). In both instances, relaxing both Mu¨ller’s muscle and the levator aponeurosis is necessary. This is best achieved under local anesthetic, allowing for evaluation intraoperatively of lid position. Lower lid elevation is best achieved by placing a spacer between the lower lid retractors and the tarsal plate. Our general rule of thumb is that the choice of spacer should be increasingly rigid with increasing degrees of lower lid retraction. Finally, the principles we observe in blepharoplasty are aggressive fat resection and moderate skin resection to avoid tense lids. We will often add to the blepharoplasty, some resection of periorbital fat in the upper lid, particularly temporally overlying the bone, since this fat may have increased as a result of the orbitopathy.
The key issue in managing the surgical paradigm for thyroid orbitopathy is to recognize that this may be complex and must be individualized based on the activity and severity of disease. I have included a table describing the range of choices with regard to decompressive surgery in Graves’ orbitopathy (Table 1).
282 |
Rootman |
REFERENCES
1.Marcocci C, Batalena L, Marino M, Rocchi R, Mazzi B, Menconi F, Morabito E, Pincera A. Current medical management of Graves’ ophthalmopathy. Ophthal Plast Reconstr Surg 2002; 18(6):402–408.
2.Rootman J. Diseases of the Orbit: A Multidisciplinary
Approach. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2003.
3.Siracuse-Lee DE, Kazim M. Orbital decompression: current concepts. Curr Opin Ophthalmol 2002; 13(5):310–316.
4.Rootman J, Stewart B, Goldberg RA. Decompression for thyroid orbitopathy. In: Orbital Surgery: A Conceptual Approach. Philadelphia: Lippincott-Raven, 1995:353–384.
5.Shorr N, Neuhaus RW, Baylis HI. Ocular motility problems after orbital decompression for dysthyroid ophthalmopathy. Ophthalmology 1982; 89(4):323–328.
6.Nugent RA, Belkin RI, Neigel JM, Rootman J, Robertson WD, Spinelli J, Graeb DA. Graves’ orbitopathy: correlation of CT and clinical findings. Radiology 1990; 177(3):675–682.
7.Nunery WR, Nunery CW, Martin RT, Truong TV, Osborn DR. The risk of diplopia following orbital floor and medial wall decompression in subtypes of ophthalmic Graves’ disease. Ophthal Plast Reconstr Surg 2000; 13(3):153–160.
8.Rootman J. Aspects of current management of thyroid orbitopathy in Asians. Asia Pac J Ophthalmol 1998; 10(3):2–6.
9.Liao SL, Kao SCS, Hou PK, Chen MS. Results of orbital decompression in Taiwan. Orbit 2001; 20(4):267–274.
10.Rootman J. Decompression for thyroid orbitopathy: current concepts. Ophthalmic Pract 1997; 15(6):222–228.
11.Hurwitz JJ, Birt D. An individualized approach to orbital decompression in Graves’ orbitopathy. Arch Ophthalmol 1985; 103(5):660–665.
12.Kalmann R, Mourits MP. Late recurrence of unilateral Graves’ orbitopathy on the contralateral side. Am J Ophthalmol 2002; 133(5):727–729.
Surgical Paradigms in Managing Thyroid Orbitopathy |
283 |
13.Goldberg RA. The evolving paradigm of orbital decompression surgery. Arch Ophthalmol 1998; 116(1):95–96.
14.Kazim M, Trokel SL, Acaroglu G, Elliott A. Reversal of dysthyroid optic neuropathy following orbital fat decompression. Br J Ophthalmol 2000; 84(6):600–605.
15.Lueder GT, Scott WE, Kutschke PJ, Keech RV. Long-term results of adjustable suture surgery for strabismus secondary to thyroid ophthalmopathy. Ophthalmology 1992; 99(6): 993–997.
16.Harvey JT, Anderson RL. The aponeurotic approach to eyelid retraction. Ophthalmology 1981; 88(6):513–524.
17.Mourits MP, Sasim IV. A single technique to correct various degrees of upper lid retraction in patients with Graves’ orbitopathy. Br J Ophthalmol 1999; 83(1):81–84.
18.Thaller VT, Kaden K, Lane CM, Collin JRO. Thyroid lid surgery. Eye 1987; 1(Pt 5):609–614.
25
Graves’ Orbitopathy: New and
Future Treatment
MICHAEL KAZIM
Columbia University,
New York, New York, U.S.A.
Predicting the future is always risky business. While an advanced understanding of the cellular basis of Graves’ orbitopathy holds great promise for a more rational therapeutic approach, often it is the unexpected development that fundamentally transforms the horizon. With this caveat, I will attempt to identify the more provocative recent reports and provide a view of the future, as flawed as it may prove to be.
For the most part, Graves’ disease has been subject to descriptive clinical analysis for the 60 years following the first report by Robert Graves in 1834, followed shortly thereafter by Von Basedow. Identification of lid retraction, lid lag, and strabismus were all completed before the turn of the 19th century. Surgical maneuvers to reduce the resulting proptosis followed, as did procedures to reverse lid retraction and
285
